Chiron Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,440
| Closed | -$276K | – | 125 |
|
|
2025
Q1 | $276K | Hold |
2,440
| – | – | 0.25% | 89 |
|
|
2024
Q4 | $258K | Sell |
2,440
-100
| -4% | -$10.6K | 0.24% | 92 |
|
|
2024
Q3 | $274K | Buy |
2,540
+100
| +4% | +$10.8K | 0.24% | 92 |
|
|
2024
Q2 | $265K | Buy |
+2,440
| New | +$265K | 0.25% | 92 |
|
|
2023
Q3 | – | Sell |
-1,740
| Closed | -$253K | – | 130 |
|
|
2023
Q2 | $253K | Sell |
1,740
-2,400
| -58% | -$349K | 0.2% | 89 |
|
|
2023
Q1 | $535K | Sell |
4,140
-3,700
| -47% | -$478K | 0.37% | 59 |
|
|
2022
Q4 | $1,000K | Sell |
7,840
-1,600
| -17% | -$204K | 0.7% | 32 |
|
|
2022
Q3 | $987K | Buy |
9,440
+300
| +3% | +$31.4K | 0.66% | 30 |
|
|
2022
Q2 | $960K | Buy |
9,140
+600
| +7% | +$63K | 0.61% | 37 |
|
|
2022
Q1 | $1.09M | Buy |
8,540
+2,937
| +52% | +$376K | 0.69% | 32 |
|
|
2021
Q4 | $691K | Buy |
5,603
+4,017
| +253% | +$495K | 0.5% | 49 |
|
|
2021
Q3 | $225K | Buy |
+1,586
| New | +$225K | 0.16% | 90 |
|
|
2020
Q4 | – | Sell |
-41
| Closed | -$5K | – | 455 |
|
|
2020
Q3 | $5K | Buy |
+41
| New | +$5K | ﹤0.01% | 374 |
|